{"id":"W2095707498","doi":"10.1136/jnnp-2013-307282","title":"Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial","year":2014,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Bayer HealthCare; Celgene; Actelion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Pfizer; Sanofi; National Multiple Sclerosis Society","keywords":"Tolerability; Medicine; Placebo; Internal medicine; Adverse effect; Gastroenterology; Clinical endpoint; Anesthesia; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002150276,0.0003092128,0.0007564271,0.0003521662,0.0001809048,0.00003727464,0.0003661738,0.0003155055,0.00001256133],"category_scores_gemma":[0.001847005,0.0002859926,0.0005271205,0.0002533364,0.0001010661,0.00002443268,0.0001068696,0.0006893621,0.00000206901],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000492031,"about_ca_system_score_gemma":0.0001998585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004932261,"about_ca_topic_score_gemma":0.000009771386,"domain_scores_codex":[0.9965289,0.000862259,0.001368408,0.0004636568,0.0002694578,0.0005073415],"domain_scores_gemma":[0.9980859,0.0002513452,0.0009615456,0.00039043,0.0001163304,0.0001944312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2407377,0.001908117,0.03456177,0.00002450503,0.0000831507,0.0000413907,0.00006851441,0.0009140529,0.7131442,0.00003015676,0.004694583,0.00379189],"study_design_scores_gemma":[0.8952351,0.01604918,0.0251601,0.0002099463,0.0003266915,0.001295178,0.000055037,0.001948839,0.02250239,0.0004668916,0.03565478,0.001095897],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874595,0.0009035107,0.0006289611,0.001372782,0.009291071,0.000262105,0.00000354732,0.00001422791,0.00006429652],"genre_scores_gemma":[0.9918585,0.0002123314,0.0005115481,0.004421225,0.002898681,0.00001119904,0.000006400773,0.00005758116,0.00002255793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6906418,"threshold_uncertainty_score":0.9999592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02120946325481602,"score_gpt":0.2571644914723998,"score_spread":0.2359550282175838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}